Sweden Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Sweden Pharmaceuticals and Healthcare Report

Sweden Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Sweden Pharmaceuticals and Healthcare Report
Published May 20, 2016
93 pages — Published May 20, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

BMI View: While Sweden s pharmaceutical market is small compared with its Western European neighbours, the country s high public expenditure on health and its favourable business environment are major factors in making it an attractive place in which to set up operations. Adding to these factors, the country s high per-capita drug expenditure levels and a rising pensionable population will see pharmaceuticals continue to be in demand, providing substantial revenue-generating opportunities for multinational pharmaceutical firms. ...

...All information contained in this publication is copyrighted in the name of Business Monitor International Ltd, and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. ...

...According to the Swedish Association of the Pharmaceutical Industry (LIF), Sweden s total expenditure for medicines has during the past decade increased much more slowly than health care costs in general. According to LIF, Life expectancy in Sweden is increasing by one year every six years. ...According to the Swedish Association of the Pharmaceutical Industry (LIF), Sweden s total expenditure for medicines has during the past decade increased much more slowly than health care costs in general. According to LIF, Life expectancy in Sweden is increasing by one year every six years. One-third of this increase is attributed to new medical treatments. ...One-third of this increase is attributed to new medical treatments. According to the International Diabetes Federation, there were ---,--- cases of diabetes in Sweden in ----.

...The country s liberalised pharmacy market is to provide opportunities in the retail sector and potentially boost Sweden s OTC market. ...The country s liberalised pharmacy market is to provide opportunities in the retail sector and potentially boost Sweden s OTC market. One of the top -- Western European economies by value of GDP, which should facilitate continued spending on high-value drugs in the medium term. Strong interest in high value-added biotechnology and development of orphan and speciality treatments, supported by highly qualified staff. ...

  
Source:
Document ID
2044-5660
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Sweden Pharmaceuticals and Healthcare Report" May 20, 2016. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Sweden-Pharmaceuticals-and-Healthcare-Report-2026-2765>
  
APA:
Business Monitor International - Industry Reports. (2016). Sweden Pharmaceuticals and Healthcare Report May 20, 2016. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Sweden-Pharmaceuticals-and-Healthcare-Report-2026-2765>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.